Injectable Drug Delivery Devices-Global Market Status and Trend Report 2013-2023
Report Summary
Injectable Drug Delivery Devices-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Injectable Drug Delivery Devices industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Injectable Drug Delivery Devices 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Injectable Drug Delivery Devices worldwide, with company and product introduction, position in the Injectable Drug Delivery Devices market
Market status and development trend of Injectable Drug Delivery Devices by types and applications
Cost and profit status of Injectable Drug Delivery Devices, and marketing status
Market growth drivers and challenges
The report segments the global Injectable Drug Delivery Devices market as:
Global Injectable Drug Delivery Devices Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Injectable Drug Delivery Devices Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Conventional Drug Delivery Devices
Novel Drug Delivery Devices
Global Injectable Drug Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Others
Global Injectable Drug Delivery Devices Market: Manufacturers Segment Analysis (Company and Product introduction, Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin):
Alkermes Inc.
Genentech Inc.
Bend Research
QLT Inc.
Endocyte
BIND Biosciences, Inc.
UCB Group (UCB)
Presage Bioscience
Polymer Factory
MicroCHIPS, Inc.
Pearl Therapeutics Inc.
Piedmont Pharmaceuticals
Zogenix, Inc.
Liquidia Technologies
Impax Laboratories Inc.
Boehringer Ingelheim
Crossject Medical Technology
Apogee Technology
Pulmatrix
Medicago
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Injectable Drug Delivery Devices-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Injectable Drug Delivery Devices industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Injectable Drug Delivery Devices 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Injectable Drug Delivery Devices worldwide, with company and product introduction, position in the Injectable Drug Delivery Devices market
Market status and development trend of Injectable Drug Delivery Devices by types and applications
Cost and profit status of Injectable Drug Delivery Devices, and marketing status
Market growth drivers and challenges
The report segments the global Injectable Drug Delivery Devices market as:
Global Injectable Drug Delivery Devices Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Injectable Drug Delivery Devices Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Conventional Drug Delivery Devices
Novel Drug Delivery Devices
Global Injectable Drug Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Others
Global Injectable Drug Delivery Devices Market: Manufacturers Segment Analysis (Company and Product introduction, Injectable Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin):
Alkermes Inc.
Genentech Inc.
Bend Research
QLT Inc.
Endocyte
BIND Biosciences, Inc.
UCB Group (UCB)
Presage Bioscience
Polymer Factory
MicroCHIPS, Inc.
Pearl Therapeutics Inc.
Piedmont Pharmaceuticals
Zogenix, Inc.
Liquidia Technologies
Impax Laboratories Inc.
Boehringer Ingelheim
Crossject Medical Technology
Apogee Technology
Pulmatrix
Medicago
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF INJECTABLE DRUG DELIVERY DEVICES
1.1 Definition of Injectable Drug Delivery Devices in This Report
1.2 Commercial Types of Injectable Drug Delivery Devices
1.2.1 Conventional Drug Delivery Devices
1.2.2 Novel Drug Delivery Devices
1.3 Downstream Application of Injectable Drug Delivery Devices
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Development History of Injectable Drug Delivery Devices
1.5 Market Status and Trend of Injectable Drug Delivery Devices 2013-2023
1.5.1 Global Injectable Drug Delivery Devices Market Status and Trend 2013-2023
1.5.2 Regional Injectable Drug Delivery Devices Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Injectable Drug Delivery Devices 2013-2017
2.2 Sales Market of Injectable Drug Delivery Devices by Regions
2.2.1 Sales Volume of Injectable Drug Delivery Devices by Regions
2.2.2 Sales Value of Injectable Drug Delivery Devices by Regions
2.3 Production Market of Injectable Drug Delivery Devices by Regions
2.4 Global Market Forecast of Injectable Drug Delivery Devices 2018-2023
2.4.1 Global Market Forecast of Injectable Drug Delivery Devices 2018-2023
2.4.2 Market Forecast of Injectable Drug Delivery Devices by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Injectable Drug Delivery Devices by Types
3.2 Sales Value of Injectable Drug Delivery Devices by Types
3.3 Market Forecast of Injectable Drug Delivery Devices by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Injectable Drug Delivery Devices by Downstream Industry
4.2 Global Market Forecast of Injectable Drug Delivery Devices by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Injectable Drug Delivery Devices Market Status by Countries
5.1.1 North America Injectable Drug Delivery Devices Sales by Countries (2013-2017)
5.1.2 North America Injectable Drug Delivery Devices Revenue by Countries (2013-2017)
5.1.3 United States Injectable Drug Delivery Devices Market Status (2013-2017)
5.1.4 Canada Injectable Drug Delivery Devices Market Status (2013-2017)
5.1.5 Mexico Injectable Drug Delivery Devices Market Status (2013-2017)
5.2 North America Injectable Drug Delivery Devices Market Status by Manufacturers
5.3 North America Injectable Drug Delivery Devices Market Status by Type (2013-2017)
5.3.1 North America Injectable Drug Delivery Devices Sales by Type (2013-2017)
5.3.2 North America Injectable Drug Delivery Devices Revenue by Type (2013-2017)
5.4 North America Injectable Drug Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Injectable Drug Delivery Devices Market Status by Countries
6.1.1 Europe Injectable Drug Delivery Devices Sales by Countries (2013-2017)
6.1.2 Europe Injectable Drug Delivery Devices Revenue by Countries (2013-2017)
6.1.3 Germany Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.4 UK Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.5 France Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.6 Italy Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.7 Russia Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.8 Spain Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.9 Benelux Injectable Drug Delivery Devices Market Status (2013-2017)
6.2 Europe Injectable Drug Delivery Devices Market Status by Manufacturers
6.3 Europe Injectable Drug Delivery Devices Market Status by Type (2013-2017)
6.3.1 Europe Injectable Drug Delivery Devices Sales by Type (2013-2017)
6.3.2 Europe Injectable Drug Delivery Devices Revenue by Type (2013-2017)
6.4 Europe Injectable Drug Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Injectable Drug Delivery Devices Market Status by Countries
7.1.1 Asia Pacific Injectable Drug Delivery Devices Sales by Countries (2013-2017)
7.1.2 Asia Pacific Injectable Drug Delivery Devices Revenue by Countries (2013-2017)
7.1.3 China Injectable Drug Delivery Devices Market Status (2013-2017)
7.1.4 Japan Injectable Drug Delivery Devices Market Status (2013-2017)
7.1.5 India Injectable Drug Delivery Devices Market Status (2013-2017)
7.1.6 Southeast Asia Injectable Drug Delivery Devices Market Status (2013-2017)
7.1.7 Australia Injectable Drug Delivery Devices Market Status (2013-2017)
7.2 Asia Pacific Injectable Drug Delivery Devices Market Status by Manufacturers
7.3 Asia Pacific Injectable Drug Delivery Devices Market Status by Type (2013-2017)
7.3.1 Asia Pacific Injectable Drug Delivery Devices Sales by Type (2013-2017)
7.3.2 Asia Pacific Injectable Drug Delivery Devices Revenue by Type (2013-2017)
7.4 Asia Pacific Injectable Drug Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Injectable Drug Delivery Devices Market Status by Countries
8.1.1 Latin America Injectable Drug Delivery Devices Sales by Countries (2013-2017)
8.1.2 Latin America Injectable Drug Delivery Devices Revenue by Countries (2013-2017)
8.1.3 Brazil Injectable Drug Delivery Devices Market Status (2013-2017)
8.1.4 Argentina Injectable Drug Delivery Devices Market Status (2013-2017)
8.1.5 Colombia Injectable Drug Delivery Devices Market Status (2013-2017)
8.2 Latin America Injectable Drug Delivery Devices Market Status by Manufacturers
8.3 Latin America Injectable Drug Delivery Devices Market Status by Type (2013-2017)
8.3.1 Latin America Injectable Drug Delivery Devices Sales by Type (2013-2017)
8.3.2 Latin America Injectable Drug Delivery Devices Revenue by Type (2013-2017)
8.4 Latin America Injectable Drug Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Injectable Drug Delivery Devices Market Status by Countries
9.1.1 Middle East and Africa Injectable Drug Delivery Devices Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Injectable Drug Delivery Devices Revenue by Countries (2013-2017)
9.1.3 Middle East Injectable Drug Delivery Devices Market Status (2013-2017)
9.1.4 Africa Injectable Drug Delivery Devices Market Status (2013-2017)
9.2 Middle East and Africa Injectable Drug Delivery Devices Market Status by Manufacturers
9.3 Middle East and Africa Injectable Drug Delivery Devices Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Injectable Drug Delivery Devices Sales by Type (2013-2017)
9.3.2 Middle East and Africa Injectable Drug Delivery Devices Revenue by Type (2013-2017)
9.4 Middle East and Africa Injectable Drug Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
10.1 Global Economy Situation and Trend Overview
10.2 Injectable Drug Delivery Devices Downstream Industry Situation and Trend Overview
CHAPTER 11 INJECTABLE DRUG DELIVERY DEVICES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Injectable Drug Delivery Devices by Major Manufacturers
11.2 Production Value of Injectable Drug Delivery Devices by Major Manufacturers
11.3 Basic Information of Injectable Drug Delivery Devices by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Injectable Drug Delivery Devices Major Manufacturer
11.3.2 Employees and Revenue Level of Injectable Drug Delivery Devices Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 INJECTABLE DRUG DELIVERY DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Alkermes Inc.
12.1.1 Company profile
12.1.2 Representative Injectable Drug Delivery Devices Product
12.1.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Alkermes Inc.
12.2 Genentech Inc.
12.2.1 Company profile
12.2.2 Representative Injectable Drug Delivery Devices Product
12.2.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Genentech Inc.
12.3 Bend Research
12.3.1 Company profile
12.3.2 Representative Injectable Drug Delivery Devices Product
12.3.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Bend Research
12.4 QLT Inc.
12.4.1 Company profile
12.4.2 Representative Injectable Drug Delivery Devices Product
12.4.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of QLT Inc.
12.5 Endocyte
12.5.1 Company profile
12.5.2 Representative Injectable Drug Delivery Devices Product
12.5.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Endocyte
12.6 BIND Biosciences, Inc.
12.6.1 Company profile
12.6.2 Representative Injectable Drug Delivery Devices Product
12.6.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of BIND Biosciences, Inc.
12.7 UCB Group (UCB)
12.7.1 Company profile
12.7.2 Representative Injectable Drug Delivery Devices Product
12.7.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of UCB Group (UCB)
12.8 Presage Bioscience
12.8.1 Company profile
12.8.2 Representative Injectable Drug Delivery Devices Product
12.8.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Presage Bioscience
12.9 Polymer Factory
12.9.1 Company profile
12.9.2 Representative Injectable Drug Delivery Devices Product
12.9.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Polymer Factory
12.10 MicroCHIPS, Inc.
12.10.1 Company profile
12.10.2 Representative Injectable Drug Delivery Devices Product
12.10.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of MicroCHIPS, Inc.
12.11 Pearl Therapeutics Inc.
12.11.1 Company profile
12.11.2 Representative Injectable Drug Delivery Devices Product
12.11.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Pearl Therapeutics Inc.
12.12 Piedmont Pharmaceuticals
12.12.1 Company profile
12.12.2 Representative Injectable Drug Delivery Devices Product
12.12.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Piedmont Pharmaceuticals
12.13 Zogenix, Inc.
12.13.1 Company profile
12.13.2 Representative Injectable Drug Delivery Devices Product
12.13.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Zogenix, Inc.
12.14 Liquidia Technologies
12.14.1 Company profile
12.14.2 Representative Injectable Drug Delivery Devices Product
12.14.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Liquidia Technologies
12.15 Impax Laboratories Inc.
12.15.1 Company profile
12.15.2 Representative Injectable Drug Delivery Devices Product
12.15.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Impax Laboratories Inc.
12.16 Boehringer Ingelheim
12.17 Crossject Medical Technology
12.18 Apogee Technology
12.19 Pulmatrix
12.20 Medicago
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
13.1 Industry Chain of Injectable Drug Delivery Devices
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
14.1 Cost Structure Analysis of Injectable Drug Delivery Devices
14.2 Raw Materials Cost Analysis of Injectable Drug Delivery Devices
14.3 Labor Cost Analysis of Injectable Drug Delivery Devices
14.4 Manufacturing Expenses Analysis of Injectable Drug Delivery Devices
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Injectable Drug Delivery Devices in This Report
1.2 Commercial Types of Injectable Drug Delivery Devices
1.2.1 Conventional Drug Delivery Devices
1.2.2 Novel Drug Delivery Devices
1.3 Downstream Application of Injectable Drug Delivery Devices
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Others
1.4 Development History of Injectable Drug Delivery Devices
1.5 Market Status and Trend of Injectable Drug Delivery Devices 2013-2023
1.5.1 Global Injectable Drug Delivery Devices Market Status and Trend 2013-2023
1.5.2 Regional Injectable Drug Delivery Devices Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Injectable Drug Delivery Devices 2013-2017
2.2 Sales Market of Injectable Drug Delivery Devices by Regions
2.2.1 Sales Volume of Injectable Drug Delivery Devices by Regions
2.2.2 Sales Value of Injectable Drug Delivery Devices by Regions
2.3 Production Market of Injectable Drug Delivery Devices by Regions
2.4 Global Market Forecast of Injectable Drug Delivery Devices 2018-2023
2.4.1 Global Market Forecast of Injectable Drug Delivery Devices 2018-2023
2.4.2 Market Forecast of Injectable Drug Delivery Devices by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Injectable Drug Delivery Devices by Types
3.2 Sales Value of Injectable Drug Delivery Devices by Types
3.3 Market Forecast of Injectable Drug Delivery Devices by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Injectable Drug Delivery Devices by Downstream Industry
4.2 Global Market Forecast of Injectable Drug Delivery Devices by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Injectable Drug Delivery Devices Market Status by Countries
5.1.1 North America Injectable Drug Delivery Devices Sales by Countries (2013-2017)
5.1.2 North America Injectable Drug Delivery Devices Revenue by Countries (2013-2017)
5.1.3 United States Injectable Drug Delivery Devices Market Status (2013-2017)
5.1.4 Canada Injectable Drug Delivery Devices Market Status (2013-2017)
5.1.5 Mexico Injectable Drug Delivery Devices Market Status (2013-2017)
5.2 North America Injectable Drug Delivery Devices Market Status by Manufacturers
5.3 North America Injectable Drug Delivery Devices Market Status by Type (2013-2017)
5.3.1 North America Injectable Drug Delivery Devices Sales by Type (2013-2017)
5.3.2 North America Injectable Drug Delivery Devices Revenue by Type (2013-2017)
5.4 North America Injectable Drug Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Injectable Drug Delivery Devices Market Status by Countries
6.1.1 Europe Injectable Drug Delivery Devices Sales by Countries (2013-2017)
6.1.2 Europe Injectable Drug Delivery Devices Revenue by Countries (2013-2017)
6.1.3 Germany Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.4 UK Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.5 France Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.6 Italy Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.7 Russia Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.8 Spain Injectable Drug Delivery Devices Market Status (2013-2017)
6.1.9 Benelux Injectable Drug Delivery Devices Market Status (2013-2017)
6.2 Europe Injectable Drug Delivery Devices Market Status by Manufacturers
6.3 Europe Injectable Drug Delivery Devices Market Status by Type (2013-2017)
6.3.1 Europe Injectable Drug Delivery Devices Sales by Type (2013-2017)
6.3.2 Europe Injectable Drug Delivery Devices Revenue by Type (2013-2017)
6.4 Europe Injectable Drug Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Injectable Drug Delivery Devices Market Status by Countries
7.1.1 Asia Pacific Injectable Drug Delivery Devices Sales by Countries (2013-2017)
7.1.2 Asia Pacific Injectable Drug Delivery Devices Revenue by Countries (2013-2017)
7.1.3 China Injectable Drug Delivery Devices Market Status (2013-2017)
7.1.4 Japan Injectable Drug Delivery Devices Market Status (2013-2017)
7.1.5 India Injectable Drug Delivery Devices Market Status (2013-2017)
7.1.6 Southeast Asia Injectable Drug Delivery Devices Market Status (2013-2017)
7.1.7 Australia Injectable Drug Delivery Devices Market Status (2013-2017)
7.2 Asia Pacific Injectable Drug Delivery Devices Market Status by Manufacturers
7.3 Asia Pacific Injectable Drug Delivery Devices Market Status by Type (2013-2017)
7.3.1 Asia Pacific Injectable Drug Delivery Devices Sales by Type (2013-2017)
7.3.2 Asia Pacific Injectable Drug Delivery Devices Revenue by Type (2013-2017)
7.4 Asia Pacific Injectable Drug Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Injectable Drug Delivery Devices Market Status by Countries
8.1.1 Latin America Injectable Drug Delivery Devices Sales by Countries (2013-2017)
8.1.2 Latin America Injectable Drug Delivery Devices Revenue by Countries (2013-2017)
8.1.3 Brazil Injectable Drug Delivery Devices Market Status (2013-2017)
8.1.4 Argentina Injectable Drug Delivery Devices Market Status (2013-2017)
8.1.5 Colombia Injectable Drug Delivery Devices Market Status (2013-2017)
8.2 Latin America Injectable Drug Delivery Devices Market Status by Manufacturers
8.3 Latin America Injectable Drug Delivery Devices Market Status by Type (2013-2017)
8.3.1 Latin America Injectable Drug Delivery Devices Sales by Type (2013-2017)
8.3.2 Latin America Injectable Drug Delivery Devices Revenue by Type (2013-2017)
8.4 Latin America Injectable Drug Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Injectable Drug Delivery Devices Market Status by Countries
9.1.1 Middle East and Africa Injectable Drug Delivery Devices Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Injectable Drug Delivery Devices Revenue by Countries (2013-2017)
9.1.3 Middle East Injectable Drug Delivery Devices Market Status (2013-2017)
9.1.4 Africa Injectable Drug Delivery Devices Market Status (2013-2017)
9.2 Middle East and Africa Injectable Drug Delivery Devices Market Status by Manufacturers
9.3 Middle East and Africa Injectable Drug Delivery Devices Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Injectable Drug Delivery Devices Sales by Type (2013-2017)
9.3.2 Middle East and Africa Injectable Drug Delivery Devices Revenue by Type (2013-2017)
9.4 Middle East and Africa Injectable Drug Delivery Devices Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
10.1 Global Economy Situation and Trend Overview
10.2 Injectable Drug Delivery Devices Downstream Industry Situation and Trend Overview
CHAPTER 11 INJECTABLE DRUG DELIVERY DEVICES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Injectable Drug Delivery Devices by Major Manufacturers
11.2 Production Value of Injectable Drug Delivery Devices by Major Manufacturers
11.3 Basic Information of Injectable Drug Delivery Devices by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Injectable Drug Delivery Devices Major Manufacturer
11.3.2 Employees and Revenue Level of Injectable Drug Delivery Devices Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 INJECTABLE DRUG DELIVERY DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Alkermes Inc.
12.1.1 Company profile
12.1.2 Representative Injectable Drug Delivery Devices Product
12.1.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Alkermes Inc.
12.2 Genentech Inc.
12.2.1 Company profile
12.2.2 Representative Injectable Drug Delivery Devices Product
12.2.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Genentech Inc.
12.3 Bend Research
12.3.1 Company profile
12.3.2 Representative Injectable Drug Delivery Devices Product
12.3.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Bend Research
12.4 QLT Inc.
12.4.1 Company profile
12.4.2 Representative Injectable Drug Delivery Devices Product
12.4.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of QLT Inc.
12.5 Endocyte
12.5.1 Company profile
12.5.2 Representative Injectable Drug Delivery Devices Product
12.5.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Endocyte
12.6 BIND Biosciences, Inc.
12.6.1 Company profile
12.6.2 Representative Injectable Drug Delivery Devices Product
12.6.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of BIND Biosciences, Inc.
12.7 UCB Group (UCB)
12.7.1 Company profile
12.7.2 Representative Injectable Drug Delivery Devices Product
12.7.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of UCB Group (UCB)
12.8 Presage Bioscience
12.8.1 Company profile
12.8.2 Representative Injectable Drug Delivery Devices Product
12.8.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Presage Bioscience
12.9 Polymer Factory
12.9.1 Company profile
12.9.2 Representative Injectable Drug Delivery Devices Product
12.9.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Polymer Factory
12.10 MicroCHIPS, Inc.
12.10.1 Company profile
12.10.2 Representative Injectable Drug Delivery Devices Product
12.10.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of MicroCHIPS, Inc.
12.11 Pearl Therapeutics Inc.
12.11.1 Company profile
12.11.2 Representative Injectable Drug Delivery Devices Product
12.11.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Pearl Therapeutics Inc.
12.12 Piedmont Pharmaceuticals
12.12.1 Company profile
12.12.2 Representative Injectable Drug Delivery Devices Product
12.12.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Piedmont Pharmaceuticals
12.13 Zogenix, Inc.
12.13.1 Company profile
12.13.2 Representative Injectable Drug Delivery Devices Product
12.13.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Zogenix, Inc.
12.14 Liquidia Technologies
12.14.1 Company profile
12.14.2 Representative Injectable Drug Delivery Devices Product
12.14.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Liquidia Technologies
12.15 Impax Laboratories Inc.
12.15.1 Company profile
12.15.2 Representative Injectable Drug Delivery Devices Product
12.15.3 Injectable Drug Delivery Devices Sales, Revenue, Price and Gross Margin of Impax Laboratories Inc.
12.16 Boehringer Ingelheim
12.17 Crossject Medical Technology
12.18 Apogee Technology
12.19 Pulmatrix
12.20 Medicago
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
13.1 Industry Chain of Injectable Drug Delivery Devices
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF INJECTABLE DRUG DELIVERY DEVICES
14.1 Cost Structure Analysis of Injectable Drug Delivery Devices
14.2 Raw Materials Cost Analysis of Injectable Drug Delivery Devices
14.3 Labor Cost Analysis of Injectable Drug Delivery Devices
14.4 Manufacturing Expenses Analysis of Injectable Drug Delivery Devices
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
